harnessing the
to transform lives

Press releases

Finch Therapeutics Presents Data from its Positive PRISM3 Trial of CP101 in Recurrent C. difficile Infection at Two Leading Medical Conferences

October 28, 2020

Finch Therapeutics Announces $90 Million Financing to Advance Pipeline of Investigational Oral Microbiome Drugs

Sep 17, 2020

Events & presentations

Jefferies Microbiome-Based Therapeutics Summit

April 22, 2021